172 filings
Page 5 of 9
8-K
h0t9w0ly e6
10 Feb 20
Other Events
7:06am
8-K
8nkq9j
9 Dec 19
Entry into a Material Definitive Agreement
8:15am
8-K
k25t3aup7ry 3cmqdi9m
4 Nov 19
Trevena Reports Third Quarter 2019 Results and Topline Data From Multi-Dose Healthy Volunteer QT Study
7:02am
8-K
6k0mpd6 kyvbfp
6 Sep 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:15pm
8-K
2ud6x19wgebo5a q5b
7 Aug 19
Trevena Reports Second Quarter 2019 Results
7:02am
8-K
g7ae6vpkqjk
27 Jun 19
Trevena Appoints Barry Shin as Chief Financial Officer
7:05am
8-K
n4esv5qx
17 May 19
Submission of Matters to a Vote of Security Holders
9:16am
8-K
9iz1mstdjt
10 May 19
Trevena Reports First Quarter 2019 Results
7:03am
8-K
i3l0 qhudgk
17 Apr 19
Entry into a Material Definitive Agreement
5:04pm
8-K
rcyo0ov
13 Mar 19
Trevena Reports Fourth Quarter and Full Year 2018 Results
7:03am
8-K
to26w0urrqyovxw1k30b
7 Mar 19
Other Events
4:02pm
8-K
wv8 eaboaqfs
1 Mar 19
Departure of Directors or Certain Officers
4:01pm
8-K
yo8ou9 r1
11 Feb 19
Other Events
4:01pm
8-K
ldz4i34pf06z8j
1 Feb 19
Entry into a Material Definitive Agreement
9:30am
8-K
0rv0gre871gq4 l0kn
30 Jan 19
Trevena Announces $10 Million Registered Direct Offering of Common Stock
7:13am
8-K
k827dywkykna2s1ckuoo
28 Jan 19
Trevena Announces Receipt of Type A Meeting Minutes and Provides Regulatory Update for Oliceridine
7:05am
8-K
l2ci5nj
21 Dec 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:00am
8-K
1q3hjxl
8 Nov 18
Trevena Reports Third Quarter 2018 Financial Results and Announces Workforce Restructuring
7:06am
8-K
0wkqlxgt1xsxgv6
2 Nov 18
Trevena Receives Complete Response Letter for Oliceridine from FDA
4:01pm
8-K
2fe4crb9ytsvmdurnzrg
17 Oct 18
Entry into a Material Definitive Agreement
4:26pm